Afatinib 40 MG Oral Tablet [Gilotrif]
Semantic Scholar uses AI to extract papers important to this topic.
Background The therapeutic landscape for non-small-cell lung cancer (NSCLC) patients that have common epidermal growth factor… Expand Afatinib [Giotrif® (EU); Gilotrif® (USA)] is an orally administered, irreversible inhibitor of the ErbB family of tyrosine… Expand Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent… Expand Afatinib (Giotrif®, Gilotrif®) is an orally administered, irreversible inhibitor of the ErbB family of tyrosine kinases. In the… Expand Background: miRNAs play a critical role in regulating key biological processes by modulating the expression of up to several… Expand Background: The differentiation of tablets by their physical appearance is a contributing factor to the safe use of medications… Expand Afatinib (Gilotrif™, Giotrif®) is an orally administered, irreversible inhibitor of the ErbB family of tyrosine kinases. Afatinib… Expand Afatinib, an irreversible inhibitor of the ErbB family of tyrosine kinases, is under development with Boehringer Ingelheim for… Expand